Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Hemophilia B, Date of authorisation: 20/02/2023, Revision: 2, Status: Authorised
TO: